Immediate Impact

8 from Science/Nature 55 standout
Sub-graph 1 of 22

Citing Papers

Digestive cancers: mechanisms, therapeutics and management
2025 Standout
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
2 intermediate papers

Works of S.-A. Im being referenced

First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors
2017

Author Peers

Author Last Decade Papers Cites
S.-A. Im 475 269 45 165 38 672
Fadi Farhat 194 231 134 65 55 669
Gianluca Del Conte 353 108 24 83 39 721
Giacomo Pelizzari 380 260 27 39 50 600
Frank Peters 417 315 66 42 32 731
Vinicius Ernani 555 406 95 77 49 815
V. Papadimitrakopoulou 307 301 53 47 41 595
Parvin F. Peddi 392 192 36 77 28 635
Xuelian Chen 455 205 146 96 35 759
Nobue Kumaki 295 142 107 40 47 588
Yongjie Shui 198 147 139 64 32 616

All Works

Loading papers...

Rankless by CCL
2026